//科室部门管理
const departmentManageConfig =
  "\t<h2>\n" +
  "\t\t<strong><span style=\";font-family:Arial;font-size:21px\"><span style=\"font-family:黑体\">科室介绍</span></span></strong>\n" +
  "\t</h2>\n" +
  "\t<p>\n" +
  "\t\t<span style=\";font-family:Calibri;font-size:14px\"><span style=\"font-family:宋体\">我院儿外科为全国规模最大、分科最细、学术水平位于国内前列的小儿外科临床、教学及科研中心。</span>1965<span style=\"font-family:宋体\">年由我国小儿外科创始人陈文龙教授、王赞尧教授创立。经过半个多世纪三代医务工作者努力奋斗，我院胃肠外科和新生儿外科在医疗教学、科研方面已建成国内领先的专科。在国内小儿胃肠及新生儿外科学术水平领先的项目： </span><span style=\"font-family:Calibri\">1.</span><span style=\"font-family:宋体\">小儿急腹症早期诊断治疗</span><span style=\"font-family:Calibri\">,</span><span style=\"font-family:宋体\">连续</span><span style=\"font-family:Calibri\">30</span><span style=\"font-family:宋体\">年</span><span style=\"font-family:Calibri\">10500</span><span style=\"font-family:宋体\">例阑尾术仅</span><span style=\"font-family:Calibri\">1</span><span style=\"font-family:宋体\">例死亡，</span><span style=\"font-family:Calibri\">4000</span><span style=\"font-family:宋体\">例肠套无死亡，国内领先，优于欧美国家</span><span style=\"font-family:Calibri\">1/1000</span><span style=\"font-family:宋体\">死亡率。 </span><span style=\"font-family:Calibri\">2.</span><span style=\"font-family:宋体\">小儿短肠综合征诊断治疗及病理研究，新生儿外科病人营养支持。 </span><span style=\"font-family:Calibri\">3.</span><span style=\"font-family:宋体\">先天性巨结肠首创根治手术方式，即经肛门直肠乙状结肠切除斜形吻合术，</span><span style=\"font-family:Calibri\">6</span><span style=\"font-family:宋体\">年近</span><span style=\"font-family:Calibri\">500</span><span style=\"font-family:宋体\">例，创伤小，手术时间短，并发症少，显著优于目前国内外流行的</span><span style=\"font-family:Calibri\">Torrt</span><span style=\"font-family:宋体\">手术。 </span><span style=\"font-family:Calibri\">4.</span><span style=\"font-family:宋体\">新生儿期（</span><span style=\"font-family:Calibri\">0~3</span><span style=\"font-family:宋体\">月）先天性巨结肠诊断标准、手术治疗、病理及发病机制研究，参加卫生部专家组制定先天性巨结肠临床路径，与病理科合作首次采用</span><span style=\"font-family:Calibri\">CR</span><span style=\"font-family:宋体\">提高早期诊断率，显著优于目前流行的乙酰胆碱酯酶方法。 </span><span style=\"font-family:Calibri\">5.Pena</span><span style=\"font-family:宋体\">手术治疗先天性肛门闭锁，近</span><span style=\"font-family:Calibri\">10</span><span style=\"font-family:宋体\">年高位肛门闭锁均无严重大便失禁病例发生。 </span><span style=\"font-family:Calibri\">6.</span><span style=\"font-family:宋体\">一次性直肠、阴道、尿道成形术治疗一穴肛，突破二次成形严重并发症，获得良好临床效果。 </span><span style=\"font-family:Calibri\">7.</span><span style=\"font-family:宋体\">婴幼儿肠套叠病因研究及美克尔憩室诊断新方法的实验研究。 </span><span style=\"font-family:Calibri\">8.</span><span style=\"font-family:宋体\">小儿血管瘤</span><span style=\"font-family:Calibri\">20</span><span style=\"font-family:宋体\">多年治疗</span><span style=\"font-family:Calibri\">80000</span><span style=\"font-family:宋体\">余例，数量多，疗效好，影响广，相关基础研究具有原始创新性，已成为我国小儿血管瘤、淋巴管瘤诊治研究中心。 </span><span style=\"font-family:Calibri\">9.</span><span style=\"font-family:宋体\">微创外科：我院开展小儿腹腔镜技术进行了胆道探查、胆囊切除、幽门环肌切开、美克尔憩室切除、阑尾切除、疝囊高位结扎及巨结肠根治术等数百例手术，效果优良，深受病人欢迎。 </span><span style=\"font-family:Calibri\">10.</span><span style=\"font-family:宋体\">电子纤维结肠镜：</span><span style=\"font-family:Calibri\">10</span><span style=\"font-family:宋体\">多年诊治</span><span style=\"font-family:Calibri\">1000</span><span style=\"font-family:宋体\">多例，无一例出现严重并发症，减轻病人痛苦，减轻经济负担，疗效满意。结肠息肉、结肠腺瘤、结肠肿瘤、</span><span style=\"font-family:Calibri\">BMP</span><span style=\"font-family:宋体\">、</span><span style=\"font-family:Calibri\">Tall3, Tall4,COX2</span><span style=\"font-family:宋体\">对比研究，发现早期癌变分子指标，</span><span style=\"font-family:Calibri\">BMP</span><span style=\"font-family:宋体\">、</span><span style=\"font-family:Calibri\">Tall3, Tall4</span><span style=\"font-family:宋体\">。 </span><span style=\"font-family:Calibri\">11.</span><span style=\"font-family:宋体\">小儿肿瘤研究： </span><span style=\"font-family:Calibri\">①</span><span style=\"font-family:宋体\">发现白血病维甲酸相关耐药基因</span><span style=\"font-family:Calibri\">HA117</span><span style=\"font-family:宋体\">（已登陆世界基因库），获</span><span style=\"font-family:Calibri\">HA117</span><span style=\"font-family:宋体\">基因全长序列，制作抗体，并证明耐药功能及成人和儿童多种肿瘤</span><span style=\"font-family:Calibri\">HA117</span><span style=\"font-family:宋体\">耐药特点，</span><span style=\"font-family:Calibri\">HA117</span><span style=\"font-family:宋体\">基因作用机理初见成果。 </span><span style=\"font-family:Calibri\">②</span><span style=\"font-family:宋体\">创新一种新的肿瘤治疗方法：耐药基因转染骨髓造血干细胞，保护骨髓，大剂量化疗杀灭肿瘤干细胞实验研究，疗效显著优于常规化疗，为临床应用提供实施基础。 </span><span style=\"font-family:Calibri\">③</span><span style=\"font-family:宋体\">动态监测外周血耐药基因，为敏感化疗药物的选择提供实验依据。 </span><span style=\"font-family:Calibri\">④</span><span style=\"font-family:宋体\">阐明化疗药物血脑屏障作用机制，为克服血脑屏障，显著提高颅内肿瘤疗效提供理论。 </span><span style=\"font-family:Calibri\">⑤</span><span style=\"font-family:宋体\">证明低频海扶（</span><span style=\"font-family:Calibri\">HiFu</span><span style=\"font-family:宋体\">）幅照可降低肿瘤细胞耐药性，提高化疗疗效。 </span><span style=\"font-family:Calibri\">12.</span><span style=\"font-family:宋体\">先天性巨结肠（肠无神经节细胞症）基础研究获重要突破，经过神经嵴干细胞体外实验、斑马鱼实验、跨胎盘</span><span style=\"font-family:Calibri\">RNA</span><span style=\"font-family:宋体\">干扰实施及临床病理等研究。提出先天性巨结肠病理新理论：</span><span style=\"font-family:Calibri\">①BMP</span><span style=\"font-family:宋体\">、</span><span style=\"font-family:Calibri\">WNT</span><span style=\"font-family:宋体\">、</span><span style=\"font-family:Calibri\">Hedgehog</span><span style=\"font-family:宋体\">信号系统、</span><span style=\"font-family:Calibri\">Ret</span><span style=\"font-family:宋体\">等</span><span style=\"font-family:Calibri\">8</span><span style=\"font-family:宋体\">种易感基因异常表达可导致肠道神经迁移异常，</span><span style=\"font-family:Calibri\">②</span><span style=\"font-family:宋体\">以上因素直接影响结肠平滑肌及粘膜原发性损伤，</span><span style=\"font-family:Calibri\">③BMP</span><span style=\"font-family:宋体\">及</span><span style=\"font-family:Calibri\">Ret</span><span style=\"font-family:宋体\">等信号系统与易感基因可影响肠神经分化迁移，神经分泌等下游因素异常。</span></span>\n" +
  "\t</p>\n" +
  "\t<p >\n" +
  "\t\t<br/>\n" +
  "\t</p>\n";
export default departmentManageConfig;